Novel cryptic exons identified in introns 2 and 3 of the human dystrophin gene with duplication of exons 8-11

Kobe Journal of Medical Sciences

Volumn 52, Issue 3, 2006, Pages 61-75

  Ishibashi, Kazuto ^a   Takeshima, Yasuhiro ^a   Yagi, Mariko ^a   Nishiyama, Atsushi ^a   Matsuo, Masafumi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cryptic exon; Duchenne muscular dystrophy; Dystrophin; Splicing

Indexed keywords

DYSTROPHIN; MESSENGER RNA; PRIMER DNA;

ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DNA DETERMINATION; ELECTROCARDIOGRAM; EXON; GENE DUPLICATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE INSERTION; GENE ISOLATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRAIT; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; LYMPHOCYTE; MALE; MUSCULAR DYSTROPHY; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; THORAX RADIOGRAPHY;

ALTERNATIVE SPLICING; BASE SEQUENCE; CHILD, PRESCHOOL; DYSTROPHIN; EXONS; GENE DUPLICATION; HUMANS; INTRONS; LYMPHOCYTES; MALE; MOLECULAR SEQUENCE DATA; MUSCULAR DYSTROPHY, DUCHENNE; RNA SPLICE SITES; RNA, MESSENGER;

EID: 33744903637     PISSN: 00232513     EISSN: 18830498     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Adachi, K., Y. Takeshima, H. Wada, M. Yagi, H. Nakamura, and M. Matsuo. 2003. Heterogous dystrophin mRNA produced by a novel splice acceptor site mutation in intermediate dystrophinopathy. Pediatr Res 53:125-31.
2. Ahn, A. H., and L. M. Kunkel. 1993. The structural and functional diversity of dystrophin. Nat Genet 3:283-91.
3. Arahata, K., E. P. Hoffman, L. M. Kunkel, S. Ishiura, T. Tsukahara, T. Ishihara, N. Sunohara, I. Nonaka, E. Ozawa, and H. Sugita. 1989. Dystrophin diagnosis: comparison of dystrophin abnormalities by immunofluorescence and immunoblot analyses. Proc Natl Acad Sci USA 86:7154-8.
4. Cartegni, L., J. Wang, Z. Zhu, M. Q. Zhang, and A. R. Krainer. 2003. ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res 31:3568-71.
5. Chelly, J., H. Gilgenkrantz, J. P. Hugnot, G. Hamard, M. Lambert, D. Recan, S. Akli, M. Cometto, A. Kahn, and J. C. Kaplan. 1991. Illegitimate transcription. Application to the analysis of truncated transcripts of the dystrophin gene in nonmuscle cultured cells from Duchenne and Becker patients. J Clin Invest 88:1161-6.
6. Cooper, T. A., and W. Mattox. 1997. The regulation of splice-site selection, and its role in human disease. Am J Hum Genet 61:259-66.
7. Dwi Pramono, Z. A., Y. Takeshima, A. Surono, T. Ishida, and M. Matsuo. 2000. A novel cryptic exon in intron 2 of the human dystrophin gene evolved from an intron by acquiring consensus sequences for splicing at different stages of anthropoid evolution. Biochem Biophys Res Commun 267:321-8.
8. Galante, P. A., N. J. Sakabe, N. Kirschbaum-Slager, and S. J. de Souza. 2004. Detection and evaluation of intron retention events in the human transcriptome. Rna 10:757-65.
9. Gangopadhyay, S. B., T. G. Sherratt, J. Z. Heckmatt, V. Dubowitz, G. Miller, M. Shokeir, P. N. Ray, P. N. Strong, and R. G. Worton. 1992. Dystrophin in frameshift deletion patients with Becker muscular dystrophy. Am J Hum Genet 51:562-70.
10. Graveley, B. R. 2005. Small molecule control of pre-mRNA splicing. Rna 11:355-8.
11. Hagiwara, Y., H. Nishio, Y. Kitoh, Y. Takeshima, N. Narita, H. Wada, M. Yokoyama, H. Nakamura, and M. Matsuo. 1994. A novel point mutation (G-1 to T) in a 5′ splice donor site of intron 13 of the dystrophin gene results in exon skipping and is responsible for Becker muscular dystrophy. Am J Hum Genet 54:53-61.
12. Hatton, A. R., V. Subramaniam, and A. J. Lopez. 1998. Generation of alternative Ultrabithorax isoforms and stepwise removal of a large intron by resplicing at exon-exon junctions. Mol Cell 2:787-96.
13. Janssen, B., C. Hartmann, V. Scholz, A. Jauch, and J. Zschocke. 2005. MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls. Neurogenetics 6:29-35.
14. Koenig, M., E. P. Hoffman, C. J. Bertelson, A. P. Monaco, C. Feener, and L. M. Kunkel. 1987. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509-17.
15. Kozak, M. 2002. Pushing the limits of the scanning mechanism for initiation of translation. Gene 299:1-34.
16. Krawczak, M., J. Reiss, and D. N. Cooper. 1992. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41-54.
17. Malhotra, S. B., K. A. Hart, H. J. Klamut, N. S. Thomas, S. E. Bodrug, A. H. Burghes, M. Bobrow, P. S. Harper, M. W. Thompson, P. N. Ray, and et al. 1988. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science 242:755-9.
18. Matsuo, M., T. Masumura, H. Nishio, T. Nakajima, Y. Kitoh, T. Takumi, J. Koga, and H. Nakamura. 1991. Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy kobe. J Clin Invest 87:2127-31.
19. Monaco, A. P., C. J. Bertelson, S. Liechti-Gallati, H. Moser, and L. M. Kunkel. 1988. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2:90-5.
20. Muntoni, F., P. Gobbi, C. Sewry, T. Sherratt, J. Taylor, S. K. Sandhu, S. Abbs, R. Roberts, S. V. Hodgson, M. Bobrow, and et al. 1994. Deletions in the 5′ region of dystrophin and resulting phenotypes. J Med Genet 31:843-7.
21. Nishio, H., Y. Takeshima, N. Narita, H. Yanagawa, Y. Suzuki, Y. Ishikawa, R. Minami, H. Nakamura, and M. Matsuo. 1994. Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter. J Clin Invest 94:1037-42.
22. Reiss, J., and F. Rininsland. 1994. An explanation for the constitutive exon 9 cassette splicing of the DMD gene. Hum Mol Genet 3:295-8.
23. Roberts, R. G., D. R. Bentley, and M. Bobrow. 1993. Infidelity in the structure of ectopic transcripts: a novel exon in lymphocyte dystrophin transcripts. Hum Mutat 2:293-9.
24. Roca, X., R. Sachidanandam, and A. R. Krainer. 2003. Intrinsic differences between authentic and cryptic 5′ splice sites. Nucleic Acids Res 31:6321-33.
25. Schaal, T. D., and T. Maniatis. 1999. Selection and characterization of pre-mRNA splicing enhancers: identification of novel SR protein-specific enhancer sequences. Mol Cell Biol 19:1705-19.
26. Senapathy, P., M. B. Shapiro, and N. L. Harris. 1990. Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project. Methods Enzymol 183:252-78.
27. Shapiro, M. B., and P. Senapathy. 1987. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 15:7155-74.
28. Shiga, N., Y. Takeshima, H. Sakamoto, K. Inoue, Y. Yokota, M. Yokoyama, and M. Matsuo. 1997. Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy. J Clin Invest 100:2204-10.
29. Sironi, M., G. Menozzi, L. Riva, R. Cagliani, G. P. Comi, N. Bresolin, R. Giorda, and U. Pozzoli. 2004. Silencer elements as possible inhibitors of pseudoexon splicing. Nucleic Acids Res 32:1783-91.
30. Suminaga, R., Y. Takeshima, K. Adachi, M. Yagi, H. Nakamura, and M. Matsuo. 2002. A novel cryptic exon in intron 3 of the dystrophin gene was incorporated into dystrophin mRNA with a single nucleotide deletion in exon 5. J Hum Genet 47:196-201.
31. Sun, H., and L. A. Chasin. 2000. Multiple splicing defects in an intronic false exon. Mol Cell Biol 20:6414-25.
32. Surono, A., Y. Takeshima, T. Wibawa, M. Ikezawa, I. Nonaka, and M. Matsuo. 1999. Circular dystrophin RNAs consisting of exons that were skipped by alternative splicing. Hum Mol Genet 8:493-500.
33. Surono, A., Y. Takeshima, T. Wibawa, Z. A. Pramono, and M. Matsuo. 1997. Six novel transcripts that remove a huge intron ranging from 250 to 800 kb are produced by alternative splicing of the 5′ region of the dystrophin gene in human skeletal muscle. Biochem Biophys Res Commun 239:895-9.
34. Surono, A., T. Van Khanh, Y. Takeshima, H. Wada, M. Yagi, M. Takagi, M. Koizumi, and M. Matsuo. 2004. Chimeric RNA/ethylene-bridged nucleic acids promote dystrophin expression in myocytes of duchenne muscular dystrophy by inducing skipping of the nonsense mutation-encoding exon. Hum Gene Ther 15:749-57.
35. Takeshima, Y., H. Nishio, H. Sakamoto, H. Nakamura, and M. Matsuo. 1995. Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe. J Clin Invest 95:515-20.
36. Tran, V. K., Z. Zhang, M. Yagi, A. Nishiyama, Y. Habara, Y. Takeshima, and M. Matsuo. 2005. A novel cryptic exon identified in the 3′ region of intron 2 of the human dystrophin gene. J Hum Genet 50:425-33.
37. Tuffery-Giraud, S., C. Saquet, S. Chambert, and M. Claustres. 2003. Pseudoexon activation in the DMD gene as a novel mechanism for Becker muscular dystrophy. Hum Mutat 21:608-14.
38. Winnard, A. V., C. J. Klein, D. D. Coovert, T. Prior, A. Papp, P. Snyder, D. E. Bulman, P. N. Ray, P. McAndrew, W. King, and et al. 1993. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. Hum Mol Genet 2:737-44.
39. Winnard, A. V., J. R. Mendell, T. W. Prior, J. Florence, and A. H. Burghes. 1995. Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production. Am J Hum Genet 56:158-66.
40. Wuarin, J., and U. Schibler. 1994. Physical isolation of nascent RNA chains transcribed by RNA polymerase II: evidence for cotranscriptional splicing. Mol Cell Biol 14:7219-25.
41. Yagi, M., Y. Takeshima, H. Wada, H. Nakamura, and M. Matsuo. 2003. Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy. Hum Genet 112:164-70.